Cargando…
HER2 Intratumoral Heterogeneity in Breast Cancer, an Evolving Concept
SIMPLE SUMMARY: HER2 intratumoral heterogeneity (ITH) is a well-known phenomenon in breast cancer, defined as the coexistence of subpopulations of tumor cells with different HER2 gene or protein expression within a tumor. HER2 ITH has been reported in up to 40% of breast cancers and to be associated...
Autores principales: | Hou, Yanjun, Nitta, Hiroaki, Li, Zaibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216596/ https://www.ncbi.nlm.nih.gov/pubmed/37345001 http://dx.doi.org/10.3390/cancers15102664 |
Ejemplares similares
-
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
por: Kurozumi, Sasagu, et al.
Publicado: (2016) -
Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer
por: Teruya, Natsuki, et al.
Publicado: (2023) -
Intratumor heterogeneity defines treatment‐resistant HER2+ breast tumors
por: Rye, Inga H., et al.
Publicado: (2018) -
Evolving concepts of tumor heterogeneity
por: Zellmer, Victoria R, et al.
Publicado: (2014) -
Characterizing Trastuzumab-Induced Alterations in Intratumoral Heterogeneity with Quantitative Imaging and Immunohistochemistry in HER2+ Breast Cancer
por: Syed, Anum K., et al.
Publicado: (2018)